Social networks
2,795Activities
Entity types
Location
ARK Hills Sengokuyama Mori Tower, 25f, 1-chōme-9-10 Roppongi, Minato City, Tokyo, Japan
Minato City
Japan
Employees
Scale: 11-50
Estimated: 23
Engaged corporates
5Added in Motherbase
1 year, 4 months agoThe Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, and international philanthropic foundations.
Global Health Research and Development, Grantmaking, NTDs, TB, Malaria, HIV, Drugs, Vaccines, R&D, Discovery and Development, Screening, and Japanese innovation, investment, and leadership
GHIT Fund(Global Health Innovative Technology Fund) We facilitate international partnerships that bring Japanese innovation, investment, and leadership to the global fight against infectious diseases and poverty in the developing world.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Shionogi & Co., Ltd Pharmaceutical | Shionogi & Co., Ltd Pharmaceutical | Other 9 May 2024 | | |
Eisai Co., Ltd. Pharmaceutical | Eisai Co., Ltd. Pharmaceutical | Other 9 May 2024 | | |
Astellas Pharma Pharmaceutical | Astellas Pharma Pharmaceutical | Other 21 Aug 2024 | | |
Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2023 | | |
Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 21 Aug 2024 | |